FDA News
🌏 NMPA Page 2NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.
Showing 13–24 of 26 articles
PREMIA and Lind Launch Lind Asia to Revolutionize Clinical Trials with AI
Kissei Pharmaceutical Halts Tavneos Use Amid Deaths
How Medicine Forgot Women: A Missed Opportunity for Asia
Shionogi's Xocova Gains FDA Clearance for COVID-19 Post-Exposure Prevention
CDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy
Newron Pharmaceuticals to Present at Upcoming Investor Conferences
BeOne Medicines' HERIZON-GEA Phase 3 Data in NEJM: A Deep Dive for Pharma BD and Investors
Dishman Carbogen Amcis Shanghai Site Achieves NMPA GMP Compliance with Zero Findings
UCB's Bimzelx Triumph: Psoriatic Arthritis Market Implications and Competitive Landscape
Hong Kong Overhauls Drug Approval Process: What Pharma BD Teams Need to Know
Estado Actual y Acciones para Impulsar la Investigación Clínica en México: 2025
Brenus Pharma's STC-1010 IND Application Accepted by FDA